share_log

Processa Pharmaceuticals | DEFR14A: Definitive proxy statement in connection with contested solicitations

SEC announcement ·  Jun 12 02:23
Summary by Futu AI
Processa Pharmaceuticals, Inc. has filed Supplement No. 1 to its definitive proxy statement with the SEC on April 29, 2024, in preparation for its Annual Meeting of Stockholders scheduled for June 28, 2024. The supplement provides a Pay Versus Performance Table, which includes detailed disclosures of executive compensation in accordance with SEC rules. The table reveals the compensation actually paid to the principal executive officers (PEOs) and non-PEO named executive officers (NEOs) for the years 2021, 2022, and 2023. The report indicates that the compensation figures are calculated as per SEC guidelines and do not represent the actual amounts earned by the executives. The supplement also includes a descriptive disclosure with graphs illustrating the relationship between the compensation paid to executives and the company's total shareholder return and net income for the same periods. This additional material is intended to inform shareholders ahead of the upcoming annual meeting where voting on company matters will take place.
Processa Pharmaceuticals, Inc. has filed Supplement No. 1 to its definitive proxy statement with the SEC on April 29, 2024, in preparation for its Annual Meeting of Stockholders scheduled for June 28, 2024. The supplement provides a Pay Versus Performance Table, which includes detailed disclosures of executive compensation in accordance with SEC rules. The table reveals the compensation actually paid to the principal executive officers (PEOs) and non-PEO named executive officers (NEOs) for the years 2021, 2022, and 2023. The report indicates that the compensation figures are calculated as per SEC guidelines and do not represent the actual amounts earned by the executives. The supplement also includes a descriptive disclosure with graphs illustrating the relationship between the compensation paid to executives and the company's total shareholder return and net income for the same periods. This additional material is intended to inform shareholders ahead of the upcoming annual meeting where voting on company matters will take place.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.